Serious Statin Associated Myotoxicity (SSAM) in Aboriginal and Torres Strait Islanders
暂无分享，去创建一个
[1] M. Dalakas,et al. Review: An update on inflammatory and autoimmune myopathies , 2011, Neuropathology and applied neurobiology.
[2] Carol Coupland,et al. Individualising the risks of statins in men and women in England and Wales: population-based cohort study , 2010, Heart.
[3] S. Greenberg,et al. Immune‐mediated necrotizing myopathy associated with statins , 2010, Muscle & nerve.
[4] Alan Cass,et al. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit , 2009, The Medical journal of Australia.
[5] R. Collins,et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.
[6] M. Lapeyre-Mestre,et al. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study , 2007, Annals of the rheumatic diseases.
[7] Alicja R Rudnicka,et al. Statin safety: a systematic review. , 2006, The American journal of cardiology.
[8] C. Black,et al. Etiology and Frequency of Rhabdomyolysis , 2002, Pharmacotherapy.
[9] D. Folzenlogen. A case of atorvastatin combined toxic myopathy and inflammatory myositis. , 2001, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.